The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study

Bird, J. et al. (2006) The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study. British Journal of Haematology, 134(4), pp. 385-390.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McQuaker, Dr Grant
Authors: Bird, J., Fuge, R., Sirohi, B., Apperley, J., Hunter, A., Snowden, J., Mahendra, P., Milligan, D., Byrne, J., Littlewood, T., Fegan, C., McQuaker, G., Pagliuca, A., Johnson, P., Rahemtulla, A., Morris, C., and Marks, D.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:British Journal of Haematology

University Staff: Request a correction | Enlighten Editors: Update this record